924671

Michael R Sperling, M.D. — FEI 3006649002

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)